vimarsana.com
Home
Live Updates
Cellectis Appoints Arthur Stril as Interim Chief Financial Officer : vimarsana.com
Cellectis Appoints Arthur Stril as Interim Chief Financial Officer : vimarsana.com
Cellectis Appoints Arthur Stril as Interim Chief Financial Officer
NEW YORK, May 02, 2024 -- Cellectis , a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today the...
Related Keywords
Raleigh ,
North Carolina ,
United States ,
Paris ,
France General ,
France ,
New York ,
Cambridge ,
Cambridgeshire ,
United Kingdom ,
French ,
Patricia Sosa Navarro ,
Bing Wang ,
Ashleyr Robinson ,
Pascalyne Wilson ,
Arthur Stril ,
Corporate Development ,
Securities Exchange Commission ,
Cellectis The Company Euronext Growth ,
Nasdaq ,
Cambridge University ,
European Commission Directorate ,
Astrazeneca ,
University Of Paris ,
French Ministry Of Health ,
Euronext Growth ,
Chief Financial Officer ,
Vice President ,
Chief Business Officer ,
Cellecti New York ,
Cellecti Board ,
Chief Executive Officer ,
European Commission ,
Hospital Financing Unit ,
French Ministry ,
Primera Therapeutics ,
Normale Sup ,
French Corps Des Mines ,
Life Science ,
Nasdaq Global Market ,
Private Securities Litigation Reform Act ,
Annual Report ,
Sosa Navarro ,
Lifesci Advisors ,
Markets ,